Request for Covid-19 Impact Assessment of this Report
Geographically, the global T-Cell Immunotherapy market is divided into North America, Europe, Latin America, Asia Pacific, Middle East & Africa.
North America, Asia and Europe have significant position in the this market, big players operating in there. The U.S. is accounting for a major share of the total T-Cell Immunotherapy market in North America.
Significant participants active in the global T-Cell Immunotherapy market include: Juno Therapeutics, Kite Pharma, Altor Bioscience Corporation, Cellectis, Adaptimmune, Novartis, Unum Therapeutics, Takara Bio, Biotecnol...
Global T-Cell Immunotherapy Market Segmentation:
T-Cell Immunotherapy market, by T-Cell Immunotherapy type:
CAR-T
TCR
TIL Therapies
…
T-Cell Immunotherapy market, by Application:
Stomach Cancer
Lung Cancer
Colorectal Cancer
Esophagus Cancer
Pancreatic Cancer
Others
…
T-Cell Immunotherapy Market Research Report 2014-2026, by region:
North America
The U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Pan Asia Pacific
China
Japan
South Korea
South East Asia Region
India
Australia
Middle East and Africa
Saudi Arabia
UAE
Qatar
Egypt
Nigeria
South Africa
Rest of MEA
The database is running updated by a group of research experts to always reflect the latest trends and information.
1. Introduction
1.1 Definition of the Market
1.2 Research Purpose
1.3 Scope of the Study
1.4 Stakeholders
1.5 Geography Coverage
1.6 Currency Under Consideration
1.7 Volume Units
1.8 Review Cycle
1.9 Summary and Key Findings of the Research
2 Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.2 Primary Data
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach (Involves time, Space, and Persons)
2.3 Data Triangulation
2.4 Assumptions
2.5 Hypothesis of this Research, Clear, Specific, and Testable Statement of This Research
2.6 Limitations of Our Study
2.7 Scene Based Modeling
2.8 Covid-19 Impact/Evaluation
3. Market Dynamics
3.1 Driving Factors
3.1.1 Rising Demand in one or More of the Following Regions: North America, Europe, Asia-Pacific, Latin America, Middle East & Africa
3.1.2 Increasing Use of T-Cell Immunotherapy by Different End-User/Applications
3.2 Restraints and Challenges in the Market
3.3 Opportunities
4. Global T-Cell Immunotherapy Market-Segmentation
4.1 By Type
4.1.1 CAR-T
4.1.2 TCR
4.1.3 TIL Therapies
4.2 By End-User/Application Industry
4.2.1 Stomach Cancer
4.2.2 Lung Cancer
4.2.3 Colorectal Cancer
4.2.4 Esophagus Cancer
4.2.5 Pancreatic Cancer
4.2.6 Others
4.3 By Geography
4.3.1 North America T-Cell Immunotherapy Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.1.1 North America T-Cell Immunotherapy Production from 2014-2020
4.3.1.2 North America T-Cell Immunotherapy Consumption from 2014-2020
4.3.1.3 North America T-Cell Immunotherapy Import and Export from 2014-2020
4.3.1.4 North America T-Cell Immunotherapy Market Value ($) and Growth (%) by Type from 2019-2020
4.3.1.5 North America T-Cell Immunotherapy Market Value ($) and Growth (%) by Application from 2019-2020
4.3.1.6 North America T-Cell Immunotherapy Market Value ($) and Growth (%) by Countries from 2019-2020
4.3.1.7 Top North America T-Cell Immunotherapy Participants Value ($) and Market Share (%) in 2019
4.3.2 Europe T-Cell Immunotherapy Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.2.1 Europe T-Cell Immunotherapy Production from 2014-2020
4.3.2.2 Europe T-Cell Immunotherapy Consumption from 2014-2020
4.3.2.3 Europe T-Cell Immunotherapy Import and Export from 2014-2020
4.3.2.4 Europe T-Cell Immunotherapy Market Value ($) and Growth (%) by Type from 2019-2020
4.3.2.5 Europe T-Cell Immunotherapy Value ($) and Growth (%) by Application from 2019-2020
4.3.2.6 Europe T-Cell Immunotherapy Market Value ($) and Growth (%) by Countries from 2019-2020
4.3.2.7 Top Europe T-Cell Immunotherapy Participants Value ($) and Market Share (%) in 2019
4.3.3 Asia-Pacific T-Cell Immunotherapy Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.3.1 Asia-Pacific T-Cell Immunotherapy Production from 2014-2020
4.3.3.2 Asia-Pacific T-Cell Immunotherapy Consumption from 2014-2020
4.3.3.3 Asia-Pacific T-Cell Immunotherapy Import and Export from 2014-2020
4.3.3.4 Asia-Pacific T-Cell Immunotherapy Value ($) and Growth (%) by Type from 2019-2020
4.3.3.5 Asia-Pacific T-Cell Immunotherapy Value ($) and Growth (%) by Application from 2019-2020
4.3.3.6 Asia-Pacific T-Cell Immunotherapy Value ($) and Growth (%) by Countries from 2019-2020
4.3.3.7 Top Asia-Pacific T-Cell Immunotherapy Participants Value ($) and Market Share (%) in 2019
4.3.4 Latin America T-Cell Immunotherapy Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.4.1 Latin America T-Cell Immunotherapy Production from 2014-2020
4.3.4.2 Latin America T-Cell Immunotherapy Consumption from 2014-2020
4.3.4.3 Latin America T-Cell Immunotherapy Import and Export from 2014-2020
4.3.4.4 Latin America T-Cell Immunotherapy Value ($) and Growth (%) by Type from 2019-2020
4.3.4.5 Latin America T-Cell Immunotherapy Value ($) and Growth (%) by Application from 2019-2020
4.3.4.6 Latin America T-Cell Immunotherapy Value ($) and Growth (%) by Countries from 2019-2020
4.3.4.7 Top Latin America T-Cell Immunotherapy Participants Value ($) and Market Share (%) in 2019
4.3.5 Middle East & Africa T-Cell Immunotherapy Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.5.1 Middle East & Africa T-Cell Immunotherapy Production from 2014-2020
4.3.5.2 Middle East & Africa T-Cell Immunotherapy Consumption from 2014-2020
4.3.5.3 Middle East & Africa T-Cell Immunotherapy Import and Export from 2014-2020
4.3.5.4 Middle East & Africa T-Cell Immunotherapy Value ($) and Growth (%) by Type from 2019-2020
4.3.5.5 Middle East & Africa T-Cell Immunotherapy Value ($) and Growth (%) by Application from 2019-2020
4.3.5.6 Middle East & Africa T-Cell Immunotherapy Value ($) and Growth (%) by Countries from 2019-2020
4.3.5.7 Top Middle East & Africa T-Cell Immunotherapy Participants Value ($) and Market Share (%) in 2019
5. Competitive Intelligence – Company Profiles
5.1 Juno Therapeutics
5.1.1 Juno Therapeutics Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.1.2 Juno Therapeutics Sales, Growth Rate and Global Market Share from 2014-2020
5.2 Kite Pharma
5.2.1 Kite Pharma Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.2.2 Kite Pharma Sales, Growth Rate and Global Market Share from 2014-2020
5.3 Altor Bioscience Corporation
5.3.1 Altor Bioscience Corporation Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.3.2 Altor Bioscience Corporation Sales, Growth Rate and Global Market Share from 2014-2020
5.4 Cellectis
5.4.1 Cellectis Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.4.2 Cellectis Sales, Growth Rate and Global Market Share from 2014-2020
5.5 Adaptimmune
5.5.1 Adaptimmune Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.5.2 Adaptimmune Sales, Growth Rate and Global Market Share from 2014-2020
5.6 Novartis
5.6.1 Novartis Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.6.2 Novartis Sales, Growth Rate and Global Market Share from 2014-2020
5.7 Unum Therapeutics
5.7.1 Unum Therapeutics Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.7.2 Unum Therapeutics Sales, Growth Rate and Global Market Share from 2014-2020
5.8 Takara Bio
5.8.1 Takara Bio Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.8.2 Takara Bio Sales, Growth Rate and Global Market Share from 2014-2020
5.9 Biotecnol
5.9.1 Biotecnol Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.9.2 Biotecnol Sales, Growth Rate and Global Market Share from 2014-2020
6. Investment Analysis
6.1 Fundamental Analysis (Porter's Five Forces Analysis)
6.2 Technical Preparation Analysis
6.3 Risk Evaluating Analysis
6.4 Estimated Investment Pay-Back Period
7. Future Forecast of the Global T-Cell Immunotherapy Market from 2021-2026
7.1 Future Forecast of Global T-Cell Immunotherapy Market from 2021-2026 Segment by Region
7.2 Future Forecast of the Global T-Cell Immunotherapy Market from 2021-2026 Segment by Types
7.3 Future Forecast of the Global T-Cell Immunotherapy Market from 2021-2026 Segment by End-User/Applications
8 Appendix
8.1 Discussion Guide
8.2 Related Reports
8.3 Author List
9 Disclaimer
Global T-Cell Immunotherapy Market Value ($) and Growth Rate of T-Cell Immunotherapy from 2014-2026
Global T-Cell Immunotherapy Production and Growth Rate Segment by Product Types from 2014-2026F
Global T-Cell Immunotherapy Consumption and Growth Rate Segment by End-User/Application from 2014-2026E
Table Driving Factors for this Market (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa)
Table Global T-Cell Immunotherapy Production and Growth Rate Segment by Product Types from 2014-2020
Table Global T-Cell Immunotherapy Value ($) and Growth Rate Segment by Product Types from 2014-2020
Figure CAR-T of T-Cell Immunotherapy
Figure TCR of T-Cell Immunotherapy
Figure TIL Therapies of T-Cell Immunotherapy
Table Global T-Cell Immunotherapy Consumption and Growth Rate Segment by End-User/Application from 2014-2020
Table Global T-Cell Immunotherapy Value ($) and Growth Rate Segment by End-User/Application from 2014-2020
Figure Stomach Cancer of T-Cell Immunotherapy
Figure Lung Cancer of T-Cell Immunotherapy
Figure Colorectal Cancer of T-Cell Immunotherapy
Figure Esophagus Cancer of T-Cell Immunotherapy
Figure Pancreatic Cancer of T-Cell Immunotherapy
Figure Others of T-Cell Immunotherapy
Table Global T-Cell Immunotherapy Production Value ($) by Regions
Table Global T-Cell Immunotherapy Production Value Share by Regions
Table Global T-Cell Immunotherapy Production by Regions
Table Global T-Cell Immunotherapy Production Share by Regions
Table Global T-Cell Immunotherapy Consumption by Regions
Table Global T-Cell Immunotherapy Consumption Share by Regions
Figure North America T-Cell Immunotherapy Production and Growth Rate from 2014-2020
Figure North America T-Cell Immunotherapy Consumption and Growth Rate from 2014-2020
Table North America T-Cell Immunotherapy Import and Export from 2014-2020
Table North America T-Cell Immunotherapy Value ($) and Growth (%) by Type from 2019-2020
Table North America T-Cell Immunotherapy Value ($) and Growth (%) by Application from 2019-2020
Table North America T-Cell Immunotherapy Value ($) and Growth (%) by Countries from 2019-2020
Table Top North America T-Cell Immunotherapy Participants Value ($) and Market Share (%) in 2019
Figure Europe T-Cell Immunotherapy Production and Growth Rate from 2014-2020
Figure Europe T-Cell Immunotherapy Consumption and Growth Rate from 2014-2020
Table Europe T-Cell Immunotherapy Import and Export from 2014-2020
Table Europe T-Cell Immunotherapy Value ($) and Growth (%) by Type from 2019-2020
Table Europe T-Cell Immunotherapy Value ($) and Growth (%) by Application from 2019-2020
Table Europe T-Cell Immunotherapy Market Value ($) and Growth (%) by Countries from 2019-2020
Table Top Europe T-Cell Immunotherapy Participants Value ($) and Market Share (%) in 2019
Figure Asia-Pacific T-Cell Immunotherapy Production and Growth Rate from 2014-2020
Figure Asia-Pacific T-Cell Immunotherapy Consumption and Growth Rate from 2014-2020
Table Asia-Pacific T-Cell Immunotherapy Import and Export from 2014-2020
Table Asia-Pacific T-Cell Immunotherapy Value ($) and Growth (%) by Type from 2019-2020
Table Asia-Pacific T-Cell Immunotherapy Value ($) and Growth (%) by Application from 2019-2020
Table Asia-Pacific T-Cell Immunotherapy Value ($) and Growth (%) by Countries from 2019-2020
Table Top Asia-Pacific T-Cell Immunotherapy Participants Value ($) and Market Share (%) in 2019
Figure Latin America T-Cell Immunotherapy Production and Growth Rate from 2014-2020
Figure Latin America T-Cell Immunotherapy Consumption and Growth Rate from 2014-2020
Table Latin America T-Cell Immunotherapy Import and Export from 2014-2020
Table Latin America T-Cell Immunotherapy Value ($) and Growth (%) by Type from 2019-2020
Table Latin America T-Cell Immunotherapy Value ($) and Growth (%) by Application from 2019-2020
Table Latin America T-Cell Immunotherapy Value ($) and Growth (%) by Countries from 2019-2020
Table Top Latin America T-Cell Immunotherapy Participants Value ($) and Market Share (%) in 2019
Figure Middle East & Africa T-Cell Immunotherapy Production and Growth Rate from 2014-2020
Figure Middle East & Africa T-Cell Immunotherapy Consumption and Growth Rate from 2014-2020
Table Middle East & Africa T-Cell Immunotherapy Import and Export from 2014-2020
Table Middle East & Africa T-Cell Immunotherapy Value ($) and Growth (%) by Type from 2019-2020
Table Middle East & Africa T-Cell Immunotherapy Value ($) and Growth (%) by Application from 2019-2020
Table Middle East & Africa T-Cell Immunotherapy Value ($) and Growth (%) by Countries from 2019-2020
Table Top Middle East & Africa T-Cell Immunotherapy Participants Value ($) and Market Share (%) in 2019
Table Juno Therapeutics Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Juno Therapeutics Sales and Growth Rate from 2014-2020
Figure Juno Therapeutics Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Kite Pharma Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Kite Pharma Sales and Growth Rate from 2014-2020
Figure Kite Pharma Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Altor Bioscience Corporation Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Altor Bioscience Corporation Sales and Growth Rate from 2014-2020
Figure Altor Bioscience Corporation Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Cellectis Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Cellectis Sales and Growth Rate from 2014-2020
Figure Cellectis Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Adaptimmune Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Adaptimmune Sales and Growth Rate from 2014-2020
Figure Adaptimmune Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Novartis Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Novartis Sales and Growth Rate from 2014-2020
Figure Novartis Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Unum Therapeutics Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Unum Therapeutics Sales and Growth Rate from 2014-2020
Figure Unum Therapeutics Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Takara Bio Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Takara Bio Sales and Growth Rate from 2014-2020
Figure Takara Bio Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Biotecnol Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Biotecnol Sales and Growth Rate from 2014-2020
Figure Biotecnol Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Global T-Cell Immunotherapy Value ($) and Growth Rate Forecast by Regions (2021-2026)
Table Global T-Cell Immunotherapy Production and Growth Rate Forecast by Regions (2021-2026)
Table Global T-Cell Immunotherapy Consumption and Growth Rate Forecast by Regions (2021-2026)
Table Global T-Cell Immunotherapy Production and Growth Rate Forecast by Types (2021-2026)
Table Global T-Cell Immunotherapy Consumption and Growth Rate Forecast by End-User/Applications (2021-2026)
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...